See Updates to Lead Screening Requirements for All Illinois Children
Oct. 16, 2026
Effective July 1, 2026, the Illinois Department of Public Health updated state childhood blood lead testing requirements. All children will now be tested between 9 to 12 months and at 24 months. Previously, only children enrolled in Medicaid were required to be tested. Children need to be tested for enrollment into daycare, preschool and kindergarten.
Health care providers may continue to use a lead exposure screening questionnaire to annually assess children age 3 and older to determine if they also need to be screened with a blood lead test. It’s recommended that children who were previously only assessed through the questionnaire now be tested through a blood lead test.
You can help close gaps in care through patient education, careful documentation and coding and well-child visits.
Patient education: Consider sharing information with caregivers about the importance of testing. Even low levels of lead can cause serious and lasting harm, including:
- Cognitive impairment and developmental delays
- Behavioral challenges and decreased attention span
- Long‑term impacts on academic performance and overall health
Documentation and coding: Accurate and complete documentation and coding help ensure proper reporting and compliance with related quality measures. Clearly document blood lead screening information in the patient’s medical record and use appropriate Current Procedural Terminology (CPT®) or ICD-10-CM codes on claims.
| Blood lead analysis | Collection codes | Abnormal lead level in blood |
| CPT: 83655 (capillary or venous) | CPT: 36415 U1 – Venipuncture CPT: 36416 U1 – Capillary | ICD-10-CM: R78.71 |
Quality measures: Refer to Quality Care 2026, our resource on documentation and coding for Healthcare Effectiveness Data and Information Set (HEDIS®) measures. Sign in to Availity® Essentials and visit our Payer Spaces.
For Medicaid, well-child visits are a key component of the Early and Periodic Screening, Diagnostic and Treatment program to ensure preventive care requirements are met, including routine blood lead testing. Identifying elevated levels early may allow you to initiate interventions, coordinate care and educate caregivers on how to reduce or eliminate their child’s exposure.
For more information, refer to the Illinois Department of Health and Family Services and Illinois Department of Public Health for resources.
Availity is a trademark of Availity, LLC, a separate company that operates a health information network to provide electronic information exchange services to medical professionals. Availity provides administrative services to Blue Cross and Blue Shield of Illinois. BCBSIL makes no endorsement, representations or warranties regarding third party vendors and the products and services they offer.
CPT copyright 2025 American Medical Association. All rights reserved. CPT is a registered trademark of the AMA.
The material presented here is for informational and educational purposes only, is not intended to be medical advice or a definitive source for coding claims and is not a substitute for the independent medical judgment of a physician or other health care provider. Health care providers are encouraged to exercise their own independent medical judgment based upon their evaluation of their patients’ conditions and all available information, and to submit claims using the most appropriate codes based upon the medical record documentation and coding guidelines and reference materials. References to other third party sources or organizations are not a representation, warranty or endorsement of such organization. The fact that a service or treatment is described in this material, is not a guarantee that the service or treatment is a covered benefit, and members should refer to their certificate of coverage for more details, including benefits, limitations and exclusions.
HEDIS is a registered trademark of the National Committee for Quality Assurance.